Lobbying

Eurofins Transplant Genomics's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q4 2023; the issues it reports most are Medicare/Medicaid.

Eurofins Transplant Genomics

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$90K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2023
The first quarter a report named it

Lobbying by quarter

Eurofins Transplant Genomics lobbying by quarter
Eurofins Transplant Genomics lobbying by quarter
QuarterAmountReports
Q4 2023$01
Q1 2024$60K1
Q2 2024$10K1
Q3 2024$30K1
Q4 2024$30K1
Q1 2025$30K1
Q2 2025$30K1
Q3 2025$30K1
Q4 2025$20K1
Q1 2026$40K1
Q2 2026$30K1
Q3 2026$00

By issue

  • Medicare and Medicaid$310K · 11 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)11 reports
  • HOUSE OF REPRESENTATIVES11 reports
  • SENATE11 reports
  • White House Office7 reports

Firms it paid

Firm
Whitmer & Worrall$310K11 quarters

Former officials lobbying for it

Former position
ERIK KOMENDANTLegislative Director, Rep. Jason Altmire; Legislative Correspondent/Legislative Assistant, Rep. Zoe Lofgren; Policy Direcor, Blue Dog CoalitionQ2 2026
MARTIN WHITMERDeputy CoS - USDOTQ1 2026

Lobbying reports

Filed by
07/22for Q2Whitmer & Worrall$30K
04/21for Q1Whitmer & Worrall$40K
01/21for Q4 2025Whitmer & Worrall$20K
25/10/20for Q3 2025Whitmer & Worrall$30K
25/07/21for Q2 2025Whitmer & Worrall$30K
25/04/21for Q1 2025Whitmer & Worrall$30K
25/01/21for Q4 2024Whitmer & Worrall$30K
24/10/17for Q3 2024Whitmer & Worrall$30K
24/07/18for Q2 2024Whitmer & Worrall$10K
24/04/19for Q1 2024Whitmer & Worrall$60K
24/01/18for Q4 2023Whitmer & WorrallUnder $5,000
24/01/18for Q4 2023Whitmer & WorrallUnder $5,000
23/12/05for Q4 2023Whitmer & WorrallUnder $5,000
23/12/04for Q4 2023Whitmer & WorrallUnder $5,000